These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 1296295)

  • 1. [Anti-typhoid vaccines].
    Morand P; Stahl JP
    Rev Prat; 1992 Nov; 42(18):2292-4. PubMed ID: 1296295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific and cross-reactive immune response to oral Salmonella Typhi Ty21a and parenteral Vi capsular polysaccharide typhoid vaccines administered concomitantly.
    Pakkanen SH; Kantele JM; Savolainen LE; Rombo L; Kantele A
    Vaccine; 2015 Jan; 33(3):451-8. PubMed ID: 25433216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new look at typhoid vaccination. Information for the practicing physician.
    Woodruff BA; Pavia AT; Blake PA
    JAMA; 1991 Feb; 265(6):756-9. PubMed ID: 1990193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A review of the current status of enteric vaccines.
    Levine MM; Noriega F
    P N G Med J; 1995 Dec; 38(4):325-31. PubMed ID: 9522876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccines for preventing typhoid fever.
    Fraser A; Goldberg E; Acosta CJ; Paul M; Leibovici L
    Cochrane Database Syst Rev; 2007 Jul; (3):CD001261. PubMed ID: 17636661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Typhoid fever vaccines: a meta-analysis of studies on efficacy and toxicity.
    Engels EA; Falagas ME; Lau J; Bennish ML
    BMJ; 1998 Jan; 316(7125):110-6. PubMed ID: 9462316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-reactive immune response elicited by parenteral Vi polysaccharide typhoid vaccine against non-typhoid Salmonellae.
    Pakkanen SH; Kantele JM; Herzog C; Kantele A
    Vaccine; 2014 Jan; 32(5):544-51. PubMed ID: 24342246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postmarketing safety surveillance for typhoid fever vaccines from the Vaccine Adverse Event Reporting System, July 1990 through June 2002.
    Begier EM; Burwen DR; Haber P; Ball R;
    Clin Infect Dis; 2004 Mar; 38(6):771-9. PubMed ID: 14999618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progress in vaccines against typhoid fever.
    Levine MM; Ferreccio C; Black RE; Tacket CO; Germanier R
    Rev Infect Dis; 1989; 11 Suppl 3():S552-67. PubMed ID: 2669099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune responses to an oral typhoid vaccine strain that is modified to constitutively express Vi capsular polysaccharide.
    Tacket CO; Pasetti MF; Sztein MB; Livio S; Levine MM
    J Infect Dis; 2004 Aug; 190(3):565-70. PubMed ID: 15243933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of immune responses to an oral typhoid vaccine, Ty21a, in children from 2 to 5 years of age in Bangladesh.
    Bhuiyan TR; Choudhury FK; Khanam F; Saha A; Sayeed MA; Salma U; Lundgren A; Sack DA; Svennerholm AM; Qadri F
    Vaccine; 2014 Feb; 32(9):1055-60. PubMed ID: 24440210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salmonella enterica serovar Typhi Ty21a expressing human papillomavirus type 16 L1 as a potential live vaccine against cervical cancer and typhoid fever.
    Fraillery D; Baud D; Pang SY; Schiller J; Bobst M; Zosso N; Ponci F; Nardelli-Haefliger D
    Clin Vaccine Immunol; 2007 Oct; 14(10):1285-95. PubMed ID: 17687110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccines against typhoid fever.
    Guzman CA; Borsutzky S; Griot-Wenk M; Metcalfe IC; Pearman J; Collioud A; Favre D; Dietrich G
    Vaccine; 2006 May; 24(18):3804-11. PubMed ID: 16278037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccination against typhoid fever: present status.
    Ivanoff B; Levine MM; Lambert PH
    Bull World Health Organ; 1994; 72(6):957-71. PubMed ID: 7867143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe systemic reactions attributed to the acetone-inactivated parenteral typhoid vaccine.
    Hoyt RE; Herip DS
    Mil Med; 1996 Jun; 161(6):339-41. PubMed ID: 8700328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New and improved vaccines. Promising weapons against varicella, hepatitis A, and typhoid fever.
    Conrad DA; Jenson HB
    Postgrad Med; 1996 Oct; 100(4):113-8, 121-5, 127. PubMed ID: 8858086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of epidemiology in the introduction of vi polysaccharide typhoid fever vaccines in Asia.
    Acosta CJ; Galindo CM; Ochiai RL; Danovaro-Holliday MC; Page AL; Thiem VD; Park JK; Park E; Koo H; Wang XY; Abu-Elyazeed R; Ali M; Albert MJ; Ivanoff B; Pang T; Xu ZY; Clemens JD
    J Health Popul Nutr; 2004 Sep; 22(3):240-5. PubMed ID: 15609776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protecting travelers from typhoid fever.
    Rao N
    Infect Control Hosp Epidemiol; 1991 Mar; 12(3):168-72. PubMed ID: 2022863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-reactive gut-directed immune response against Salmonella enterica serovar Paratyphi A and B in typhoid fever and after oral Ty21a typhoid vaccination.
    Pakkanen SH; Kantele JM; Kantele A
    Vaccine; 2012 Sep; 30(42):6047-53. PubMed ID: 22858557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccines for preventing typhoid fever.
    Engels EA; Lau J
    Cochrane Database Syst Rev; 2000; (2):CD001261. PubMed ID: 10796623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.